Zenlabs Ethica
34.85
+1.65(+4.97%)
Market Cap₹22.67 Cr
PE Ratio-11.18
Company Performance:
1D+4.97%
1M-2.52%
6M+61.57%
1Y+6.22%
5Y-10.98%
View Company Insightsright
More news about Zenlabs Ethica
23Feb 26
Zenlabs Ethica Ltd Receives GST Demand Notice Worth ₹12.54 Lakh for Tax Period 2019-20
Zenlabs Ethica Ltd received a GST demand notice worth ₹12.54 lakh from Central GST Division-1, Derabassi, for the 2019-20 tax period. The notice alleges under-declaration of taxable turnover leading to short payment of tax liability (₹1,494), ineligible input tax credit (₹5,57,930), interest on late payment (₹4,81,708), and penalty (₹1,18,825). The company states no material impact on operations and will respond within prescribed timelines.
 no imag found
07Feb 26
Zenlabs Ethica Reports Q3FY26 Loss and Appoints New Company Secretary
Zenlabs Ethica Limited faced significant challenges in Q3FY26 with a net loss of ₹200.76 lakhs primarily due to exceptional charges of ₹207.81 lakhs related to its NBFC business exit following RBI registration cancellation in November 2025. The company simultaneously strengthened its governance by appointing Amit Kumar, an Associate ICSI member, as Company Secretary and Compliance Officer effective February 7, 2026, replacing Manju Bala who resigned in December 2025.
 no imag found
04Dec 25
Zenlabs Ethica's Company Secretary Manju Bala Resigns, Effective December 2025
Ms. Manju Bala (ACS 67831), Company Secretary and Compliance Officer of Zenlabs Ethica Limited, has resigned effective December 04, 2025, citing a better opportunity elsewhere. She provided a 15-day notice period starting November 20, 2025. The Board acknowledged her contributions. The company will file necessary forms with the Registrar of Companies, Chandigarh. No replacement has been announced yet.
 no imag found
09Aug 25
Zenlabs Ethica Reports Strong Q1 FY2026 Results with 21.9% Revenue Growth
Zenlabs Ethica Limited reported impressive Q1 FY2026 results. Revenue increased by 21.9% to ₹957.50 crore. EBITDA grew by 29.4% to ₹212.98 crore, with margin expanding to 22.2%. Profit After Tax surged by 50.9% to ₹131.90 crore. The company launched three new products, filed two ANDAs with USFDA, received approval for one generic product, and commenced production at a new facility. Zenlabs maintains a strong financial position with net cash of ₹205.98 crore.
 no imag found
08Aug 25
Zenlabs Ethica Reports Q1 Profit Dip, Adopts New Insider Trading Policies
Zenlabs Ethica Limited reported a 20.33% decrease in net profit for Q1, falling to ₹3.33 crore from ₹4.18 crore year-over-year. Revenue from operations declined by 7.16% to ₹1,147.72 crore. The company's Board approved new insider trading policies to enhance corporate governance, including codes for fair disclosure of unpublished price sensitive information and regulating insider trading.
 no imag found
Zenlabs Ethica
34.85
+1.65
(+4.97%)
1 Year Returns:+6.22%
Industry Peers
Nesco
1,099.00
(-0.05%)
Indiabulls
29.63
(+0.20%)
SIS
435.50
(-0.53%)
Nirlon
619.30
(-0.11%)
CMS Info Systems
262.40
(+1.74%)
Quess Corp
288.15
(-2.17%)
Hemisphere Properties
138.93
(+1.50%)